Company / Operating Cash Flow per Share
Nurix Therapeutics, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.29
FY2025
5-year range
-$3.54 / $0.02
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#174 of 212
Health Care
What the data says
Nurix Therapeutics, Inc.'s operating cash flow per share of $-3.29 is lower than 82% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-3.54 in FY2024 to $0.18 in FY2019.
Based on SEC 10-K filings.
-3.29 in FY2025.
Declined from $-1.72 to $-3.29 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 212This company -$3.29 Sector average $5.28
▼
-162.3% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 7.2% year-over-year.
- Ranks #174 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.29 | +7.2% |
| FY2024 | -$3.54 | -105.4% |
| FY2023 | -$1.72 | +8.7% |
| FY2022 | -$1.89 | -12314.7% |
| FY2021 | $0.02 | +169.5% |
| FY2020 | -$0.02 | -112.2% |
| FY2019 | $0.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026